The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings

Clinical Biochemistry

Volumn 47, Issue 4-5, 2014, Pages 258-266

  Shabihkhani, Maryam ^a   Lucey, Gregory M ^a   Wei, Bowen ^a   Mareninov, Sergey ^a   Lou, Jerry J ^a   Vinters, Harry V ^a   Singer, Elyse J ^a   Cloughesy, Timothy F ^a   Yong, William H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Neurology David Geffen School of Medicine at UCLA ^*  (United States)

Author keywords

Biobank; Biorepository; Biospecimen; Frozen; Procurement; Tissue

Indexed keywords

DNA; PROTEIN; RNA;

ARTICLE; BIOBANK; BLOOD BANK; BLOOD STORAGE; DEGRADATION; FREEZE THAWING; HEALTH CARE FACILITY; HUMAN; PATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN QUALITY; QUALITY CONTROL; SAMPLING; STORAGE TEMPERATURE; TISSUE PRESERVATION;

BIOBANK; BIOREPOSITORY; BIOSPECIMEN; FROZEN; PROCUREMENT; TISSUE;

ARTIFACTS; BIOLOGICAL SPECIMEN BANKS; CRYOPRESERVATION; FREEZING; GUIDELINES AS TOPIC; HUMANS; PROTEIN STABILITY; QUALITY CONTROL; RNA STABILITY; SPECIMEN HANDLING; TIME FACTORS;

EID: 84896045497     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2014.01.002     Document Type: Article

References (107)

1. World population prospects, The 2012 Revision by the United Nations Department of Economic and Social Affairs, Population Division [Accessed October 21, 2013]. http://esa.un.org/wpp/Documentation/publications.htm.
2. Vaught J., Rogers J., Carolin T., Compton C. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr 2011, 42:24-31.
3. Tang W., Hu Z., Muallem H., Gulley M.L. Quality assurance of RNA expression profiling in clinical laboratories. J Mol Diagn 2012, 14:1-11.
4. Naber S.P. Continuing role of a frozen-tissue bank in molecular pathology. Diagn Mol Pathol 1996, 5:253-259.
5. Fairley J.A., Gilmour K., Walsh K. Making the most of pathological specimens: molecular diagnosis in formalin-fixed, paraffin embedded tissue. Curr Drug Targets 2012, 13:1475-1487.
6. Shi S.R., Liu C., Pootrakul L., Tang L., Young A., Chen R., et al. Evaluation of the value of frozen tissue section used as "gold standard" for immunohistochemistry. Am J Clin Pathol 2008, 129:358-366.
7. Mareninov S., De Jesus J., Sanchez D.E., Kay A.B., Wilson R.W., Babic I., et al. Lyophilized brain tumor specimens can be used for histologic, nucleic acid, and protein analyses after 1year of room temperature storage. J Neurooncol 2013, 113:365-373.
8. Von Teichman A., Storz M., Dettwiler S., Moch H., Schraml P. Whole genome and transcriptome amplification: practicable tools for sustainable tissue biobanking?. Virchows Arch 2012, 461:571-580.
9. Leonard S., Logel J., Luthman D., Casanova M., Kirch D., Freedman R. Biological stability of mRNA isolated from human postmortem brain collections. Biol Psychiatry 1993, 33:456-466.
10. Chu T.Y., Hwang K.S., Yu M.H., Lee H.S., Lai H.C., Liu J.Y. A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites. Int J Gynecol Cancer 2002, 12:171-176.
11. Levitz J. Brain-bank glitch mars research into autism. Wall Str J June 2012, 11.
12. Mehta R., Baranova A., Birerdinc A. Do-it-yourself device for recovery of cryopreserved samples accidentally dropped into cryogenic storage tanks. J Vis Exp 2012, 63:e3903.
13. Vaught J.B., Henderson M.K., Compton C.C. Biospecimens and biorepositories: from afterthought to science. Cancer Epidemiol Biomarkers Prev 2012, 21:253-255.
14. Campbell L.D., Betsou F., Leiolani Garcia D., Giri J.G., Pitt K.E., Pugh R.S., et al. Development of the ISBER best practices for repositories: collection, storage, retrieval and distribution of biological materials for research. Biopreserv Biobank 2012, 10:232-233.
15. National Cancer Institute Best Practices for Biospecimen Resources [Accessed October21, 2013]. http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf.
16. Holland N.T., Smith M.T., Eskenazi B., Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003, 543:217-234.
17. Mager S.R., Oomen M.H., Morente M.M., Ratcliffe C., Knox K., Kerr D.J., et al. Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer 2007, 43:828-834.
18. Landi M.T., Caporaso N. Sample collection, processing and storage. IARC Sci Publ 1997, 142:223-236.
19. Srinivasan M., Sedmak D., Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol 2002, 161:1961-1971.
20. Betsou F., Barnes R., Burke T., Coppola D., Desouza Y., Eliason J., et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009, 18:1017-1025.
21. Bahn S., Augood S.J., Ryan M., Standaert D.G., Starkey M., Emson P.C. Gene expression profiling in the post-mortem human brain-no cause for dismay. J Chem Neuroanat 2001, 22:79-94.
22. Espina V., Edmiston K.H., Heiby M., Pierobon M., Sciro M., Merritt B., et al. A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteomics 2008, 7:1998-2018.
23. Espina V., Mueller C., Edmiston K., Sciro M., Petricoin E.F., Liotta L.A. Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 2009, 3:874-882.
24. Riddick A.C., Barker C., Sheriffs I., Bass R., Ellis V., Sethia K.K., et al. Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int 2003, 91:315-323.
25. Schroeder A., Mueller O., Stocker S., Salowsky R., Leiber M., Gassmann M., et al. The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol 2006, 7:3.
26. Bao W.G., Zhang X., Zhang J.G., Zhou W.J., Bi T.N., Wang J.C., et al. Biobanking of fresh-frozen human colon tissues: impact of tissue ex-vivo ischemia times and storage periods on RNA quality. Ann Surg Oncol 2013, 20:1737-1744.
27. De Cecco L., Musella V., Veneroni S., Cappelletti V., Bongarzone I., Callari M., et al. Impact of biospecimens handling on biomarker research in breast cancer. BMC Cancer 2009, 9:409.
28. Micke P., Ohshima M., Tahmasebpoor S., Ren Z.P., Ostman A., Pontén F., et al. Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens. Lab Invest 2006, 86:202-211.
29. Van Maldegem F., de Wit M., Morsink F., Musler A., Weegenaar J., Van Noesel C.J. Effects of processing delay, formalin fixation, and immunohistochemistry on RNA recovery from formalin-fixed paraffin-embedded tissue sections. Diagn Mol Pathol 2008, 17:51-58.
30. Barnes R.O., Parisien M., Murphy L.C., Watson P.H. Influence of evolution in tumor biobanking on the interpretation of translational research. Cancer Epidemiol Biomarkers Prev 2008, 17:3344-3350.
31. Hong S.H., Baek H.A., Jang K.Y., Chung M.J., Moon W.S., Kang M.J., et al. Effects of delay in the snap freezing of colorectal cancer tissues on the quality of DNA and RNA. J Korean Soc Coloproctol 2010, 26:316-323.
32. Bray S.E., Paulin F.E., Fong S.C., Baker L., Carey F.A., Levison D.A., et al. Gene expression in colorectal neoplasia: modifications induced by tissue ischaemic time and tissue handling protocol. Histopathology 2010, 56:240-250.
33. Sampaio-Silva F., Magalhães T., Carvalho F., Dinis-Oliveira R.J., Silvestre R. Profiling of RNA degradation for estimation of post mortem interval. PLoS One 2013, 8:e56507.
34. Musella V., Verderio P., Reid J.F., Pizzamiglio S., Gariboldi M., Callari M., et al. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One 2013, 8:e53406.
35. Dumur C.I., Sana S., Ladd A.C., Ferreira-Gonzalez A., Wilkinson D.S., Powers C.N., et al. Assessing the impact of tissue devitalization time on genome-wide gene expression analysis in ovarian tumor samples. Diagn Mol Pathol 2008, 17:200-206.
36. Ma Y., Dai H., Kong X. Impact of warm ischemia on gene expression analysis in surgically removed biosamples. Anal Biochem 2012, 423:229-235.
37. Walker L.A., Medway A.M., Walker J.S., Cleveland J.C., Buttrick P.M. Tissue procurement strategies affect the protein biochemistry of human heart samples. J Muscle Res Cell Motil 2011, 31:309-314.
38. Azimi-Nezhad M., Lambert D., Ottone C., Perrin C., Chapel C., Gailard G., et al. Influence of pre-analytical variables on VEGF gene expression and circulating protein concentrations. Biopreserv Biobank 2012, 10:454-461.
39. Yildiz-Aktas I.Z., Dabbs D.J., Bhargava R. The effect of cold ischemic time on the immunohistochemical evaluation of estrogen receptor, progesterone receptor, and HER2 expression in invasive breast carcinoma. Mod Pathol 2012, 25:1098-1105.
40. Recommendations for HER2 Testing in Breast Cancer: ASCO - CAP Clinical Practice Guideline Update [Accessed December 25, 2013]. http://www.cap.org/apps/docs/committees/immunohistochemistry/her2_faqs.pdf.
41. Gillio-Meina C., Cepinskas G., Cecchini E.L., Fraser D.D. Translational research in pediatrics II: blood collection, processing, shipping, and storage. Pediatrics 2013, 131:754-766.
42. Elliott P., Peakman T.C. The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int J Epidemiol 2008, 37:234-244.
43. Harding S.A., Din J.N., Sarma J., Jessop A., Weatherall M., Fox K.A., et al. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations. Thromb Haemost 2007, 98:451-456.
44. Boyanton B.L., Blick K.E. Stability studies of twenty-four analytes in human plasma and serum. Clin Chem 2002, 48:2242-2247.
45. Hsieh S.Y., Chen R.K., Pan Y.H., Lee H.L. Systematical evaluation of the effects of sample collection procedures on low-molecular-weight serum/plasma proteome profiling. Proteomics 2006, 6:3189-3198.
46. Halsall A., Ravetto P., Reyes Y., Thelwell N., Davidson A., Gaut R., et al. The quality of DNA extracted from liquid or dried blood is not adversely affected by storage at 4 degrees C for up to 24h. Int J Epidemiol 2008, 37(Suppl. 1):i7-i10.
47. Salway F., Day P.J., Ollier W.E., Peakman T. Levels of 5' RNA tags present in plasma and buffy coat from EDTA blood increase with time. Int J Epidemiol 2008, 37(Suppl. 1):i11-i15.
48. Tsui N.B., Ng E.K., Lo Y.M. Stability of endogenous and added RNA in blood specimens, serum and plasma. Clin Chem 2002, 48:1647-1653.
49. Qualman S.J., France M., Grizzle W.E., LiVolsi V.A., Moskaluk C.A., Ramirez N.C., et al. Establishing a tumour bank: banking, informatics and ethics. Br J Cancer 2004, 90:1115-1119.
50. Crawford D., Cowan S., Hyder S., McMenamin M., Smith D., Leake R. New storage procedure for human tumor biopsies prior to estrogen receptor measurement. Cancer Res 1984, 44:2348-2351.
51. Zeisler R., Greenberg R.R., Stone S.F., Sullivan T.M. Long-term stability of the elemental composition in biological materials. Fresenius' Z Anal Chem 1988, 332:612-615.
52. Yasojima K., McGeer E.G., McGeer P.L. High stability of mRNAs postmortem and protocols for their assessment by RT-PCR. Brain Res Brain Res Protoc 2001, 8:212-218.
53. Ericsson C., Franzén B., Nistér M. Frozen tissue biobanks. Tissue handling, cryopreservation, extraction, and use for proteomic analysis. Acta Oncol 2006, 45:461-643.
54. McLeay W.R., Horsfall D.J., Seshadri R., Morrison D.A., Saccone G.T. Epidermal growth factor receptor in breast cancer: storage conditions affecting measurement, and relationship to steroid receptors. Breast Cancer Res Treat 1992, 22:141-151.
55. Mackey E.A., Demiralp R., Fitzpatrick K.A., Porter B.J., Wise S.A., Becker P.R., et al. Quality assurance in analysis of cryogenically stored liver tissue specimens from the NIST National Biomonitoring Specimen Bank (NBSB). Sci Total Environ 1999, 226:165-176.
56. Nederhand R.J., Droog S., Kluft C., Simoons M.L., de Maat M.P. Logistics and quality control for DNA sampling in large multicenter studies. J Thromb Haemost 2003, 1:987-991.
57. Steinberg K., Beck J., Nickerson D., Garcia-Closas M., Gallagher M., Caggana M., et al. DNA banking for epidemiologic studies: a review of current practices. Epidemiology 2002, 13:246-254.
58. Steinberg K., Sanderlin K.C., Ou C.Y., Hannon W.H., McQuillan G.M., Sampson E.J. DNA banking in epidemiologic studies. Epidemiol Rev 1997, 19:156-162.
59. Grasedieck S., Schöler N., Bommer M., Niess J.H., Tumani H., Rouhi A., et al. Impact of serum storage conditions on microRNA stability. Leukemia 2012, 26:2414-2416.
60. Lewis M.R., Callas P.W., Jenny N.S., Tracy R.P. Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples. Thromb Haemost 2001, 86:1495-1500.
61. Caporaso N., Vaught J. Collection, processing, and analysis of preneoplastic specimens 2002, 33-45. Cancer Precursors. Springer, New York.
62. Chen H.I., Tsai C.D., Wang H.T., Hwang S.M. Cryovial with partial membrane sealing can prevent liquid nitrogen penetration in submerged storage. Cryobiology 2006, 53:283-287.
63. Bell W.C., Sexton K.C., Grizzle W.E. Organizational issues in providing high-quality human tissues and clinical information for the support of biomedical research. Methods Mol Biol 2010, 1-30.
64. Vonsattel J.P., Amaya Mdel P., Cortes E.P., Mancevska K., Keller C.E. Twenty-first century brain banking: practical prerequisites and lessons from the past: the experience of New York Brain Bank, Taub Institute, Columbia University. Cell Tissue Bank 2008, 9:247-258.
65. Ericsson C., Peredo I., Nistér M. Optimized protein extraction from cryopreserved brain tissue samples. Acta Oncol 2007, 46:10-20.
66. Jochumsen K.M., Tan Q., Dahlgaard J., Kruse T.A., Mogensen O. RNA quality and gene expression analysis of ovarian tumor tissue undergoing repeated thaw-freezing. Exp Mol Pathol 2007, 82:95-102.
67. Botling J., Edlund K., Segersten U., Tahmasebpoor S., Engström M., Sundström M., et al. Impact of thawing on RNA integrity and gene expression analysis in fresh frozen tissue. Diagn Mol Pathol 2009, 18:44-52.
68. Sherwood K.R., Head M.W., Walker R., Smith C., Ironside J.W., Fazakerley J.K. RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue. Neuropathol Appl Neurobiol 2011, 37:633-642.
69. Atz M., Walsh D., Cartagena P., Li J., Evans S., Choudary P., et al. Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 2007, 163:295-309.
70. Ross K.S., Haites N.E., Kelly K.F. Repeated freezing and thawing of peripheral blood and DNA in suspension: effects on DNA yield and integrity. J Med Genet 1990, 27:569-570.
71. Kopreski M.S., Benko F.A., Kwak L.W., Gocke C.D. Detection of tumor messenger RNA in the serum of patients with malignant melanoma. Clin Cancer Res 1999, 5:1961-1965.
72. Baumann S., Ceglarek U., Fiedler G.M., Lembcke J., Leichtle A., Thiery J. Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clin Chem 2005, 51:973-980.
73. Hetland M.L., Christensen I.J., Lottenburger T., Johansen J.S., Svendsen M.N., Hørslev-Petersen K., et al. Circulating VEGF as a biological marker in patients with rheumatoid arthritis? Pre-analytical and biological variability in healthy persons and in patients. Dis Markers 2008, 24:1-10.
74. Tsiatis A.C., Norris-Kirby A., Rich R.G., Hafez M.J., Gocke C.D., Eshleman J.R., et al. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 2010, 12:425-432.
75. Li M., Stoneking M. A new approach for detecting low-level mutations in next-generation sequence data. Genome Biol 2012, 13:R34.
76. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068.
77. Yong W.H., Lucey G., Hanna L., Sanchez D., Mody R., Lai A. Hematoxylin and eosin assessment of high grade glioma paraffin block adequacy for molecular analysis. J Neuropathol Exp Neurol 2013, 72:94.
78. Lodish H., Berk A., Zipursky S.L., Matsudaira P., Baltimore D., Darnell J. Molecular cell biology 2000, W. H. Freeman, New York, [Section 4.1]. 4th ed.
79. Glasel J.A. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques 1995, 18:62-63.
80. Wilfinger W.W., Mackey K., Chomczynski P. Effect of pH and ionic strength on the spectrophotometric assessment of nucleic acid purity. Biotechniques 1997, 22:478-481.
81. Jewell S.D., Srinivasan M., McCart L.M., Williams N., Grizzle W.H., LiVolsi V., et al. Analysis of the molecular quality of human tissues: an experience from the cooperative human tissue network. Am J Clin Pathol 2002, 118:733-741.
82. Fleige S., Pfaffl M.W. RNA integrity and the effect on the real-time qRT-PCR performance. Mol Aspects Med 2006, 27:126-139.
83. Fleige S., Walf V., Huch S., Prgomet C., Sehm J., Pfaffl M.W. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006, 28:1601-1613.
84. Imbeaud S., Graudens E., Boulanger V., Barlet X., Zaborski P., Eveno E., et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 2005, 33:e56.
85. Manchester K.L. Use of UV methods for measurement of protein and nucleic acid concentrations. Biotechniques 1996, 20:968-970.
86. Russell S., Meadows L.A., Russell R.R. Microarray technology in practice 2008, Academic Press. 1st ed.
87. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor Laboratory Press, New York. 2nd ed.
88. Gonzalez I.L., Sylvester J.E. rRNA genes: evolution. eLS 2006, John Wiley & Sons, Ltd.
89. Krupp G. Stringent RNA quality control using the agilent 2100 bioanalyzer. Agilent technologies application notes 2005.
90. Mueller O., Lightfoot S., Schroeder A. RNA integrity number (RIN)-standardization of RNA quality control. Agilent Application Note, Publication 2004, 1-8.
91. Bustin S.A., Nolan T. Pitfalls of quantitative real-time reverse-transcription polymerase chain reaction. J Biomol Tech 2004, 15:155-166.
92. Raman T., O'Connor T.P., Hackett N.R., Wang W., Harvey B.G., Attiyeh M.A., et al. Quality control in microarray assessment of gene expression in human airway epithelium. BMC Genomics 2009, 10:493.
93. Kiewe P., Gueller S., Komor M., Stroux A., Thiel E., Hofmann W.K. Prediction of qualitative outcome of oligonucleotide microarray hybridization by measurement of RNA integrity using the 2100 bioanalyzer capillary electrophoresis system. Ann Hematol 2009, 88:1177-1183.
94. Mayne M., Shepel P.N., Geiger J.D. Recovery of high-integrity mRNA from brains of rats killed by high-energy focused microwave irradiation. Brain Res Brain Res Protoc 1999, 4:295-302.
95. Eikmans M., Rekers N.V., Anholts J.D., Heidt S., Claas F.H. Blood cell mRNAs and microRNAs: optimized protocols for extraction and preservation. Blood 2013, 121:e81-e89.
96. Barrachina M., Castaño E., Ferrer I. TaqMan PCR assay in the control of RNA normalization in human post-mortem brain tissue. Neurochem Int 2006, 49:276-284.
97. Buesa C., Maes T., Subirada F., Barrachina M., Ferrer I. DNA chip technology in brain banks: confronting a degrading world. J Neuropathol Exp Neurol 2004, 63:1003-1014.
98. Engel K.B., Moore H.M. Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue. Arch Pathol Lab Med 2011, 135:537-543.
99. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85.
100. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
101. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
102. Geddes T.J., Ahmed S., Pruetz B.L., Larson D.M., Thibodeau B.J., Akervall J., et al. SPIN: development of sample-specific protein integrity numbers as an index of biospecimen quality. Biopreserv Biobank 2013, 11:25-32.
103. Hwang R.F., Wang H., Lara A., Gomez H., Chang T., Sieffert N., et al. Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer. Ann Surg Oncol 2008, 15:1356-1366.
104. Thasler W.E., Thasler R.M., Schelcher C., Jauch K.W. Biobanking for research in surgery: are surgeons in charge for advancing translational research or mere assistants in biomaterial and data preservation?. Langenbecks Arch Surg 2013, 398:487-499.
105. Bevilacqua G., Bosman F., Dassesse T., Höfler H., Janin A., Langer R., et al. The role of the pathologist in tissue banking: European Consensus Expert Group Report. Virchows Arch 2010, 456:449-454.
106. U.S.Energy Information Administration EIA-electric power monthly-average retail price of electricity to ultimate customers [Accessed October23, 2013]. http://www.eia.gov/electricity/monthly/epm_table_grapher.cfm?t=epmt_5_03.
107. US EPA Calculations and references, clean energy [Accessed October23, 2013]. http://www.epa.gov/cleanenergy/energy-resources/refs.html.